Ọgwụ dị n'ụdị usoro usoro ọgwụgwọ a:

• capsules gelatin siri ike: nha Nke 1, edo edo, cylindrical, juputara na ntụ ntụ sitere na odo na odo na-acha odo odo na agba, na ọnụnọ nke conglomerates na-etisa mgbe etinyere ya (pcs iri abụọ na blisters, na ngwugwu kaadi nke 5 ma ọ bụ 10 blisters),
• gel maka ojiji mpụga 2%: site na aja aja na-acha ọcha ruo odo (40 g nke ọ bụla na laminate / tubes aluminom nwere mkpuchi nke varnish na-eji eriri akpụkpọ ahụ, na ngwugwu kaadiboodu 1).

Otu Capsule nwere:

• ihe na-arụ ọrụ: troxerutin - 300 mg,
• ihe inyeaka: magnesium stearate, lactose monohydrate,
• shei: titanium dioxide (E171), anwụ na-acha anwụ anwụ na-acha odo odo (E110), daiini quinoline odo, gelatin.

1000 mg nke gel maka ihe mpụga nwere:

• ihe na-arụ ọrụ: troxerutin - 20 mg,
• ihe inyeaka: carbomer, chloride benzalkonium, trolamine (triethanolamine), disodium edetate dihydrate, mmiri dị ọcha.

Troxevasin

Ntụziaka maka ojiji:

Ọnụ ahịa ahịa ahịa n'ịntanetị:

Troxevasin (Troxevasin) bụ ọgwụ angioprotective nwere decongestant na mgbochi mkpali, eji ya na ọgwụgwọ nke venous insufficiency, varicose veins, wdg.

Ihe ngbanwe

Dịka ntuziaka ahụ si dị, Troxevasin bụ contraindicated n'ihe banyere gastritis na-adịghị ala ala, hypersensitivity na ọgwụ yana akụkụ ya, ọnya afọ na ọnya duodenal. N'iji akpachapụ anya, a na-enye ọgwụ ọgwụ ka ọghara gbasara akụrụ. N'oge ime afọ, Troxevasin na-contraindicated na ọnwa atọ.

Omume ọgwụ

Ọgwụ angioprotective nke na-arụkarị ọrụ n'isi na akwara.

Na-ebelata pores n'etiti mkpụrụ ndụ endothelial site na ịgbanwetụ akwara fibrous dị n'etiti sel endothelial. Ọ na - egbochi nchịkọta ma nwekwa ogo nke nrụrụ sel sel ọbara, na - enwe mmetụta mgbochi.

Na ezughi oke ihe na-egbu mgbu, Troxevasin ® na-ebelata ogo edema, mgbu, ihe ọdịdọ, nsogbu ọgbụgba, ọnya afọ. Na -eme ka ihe mgbaàmà metụtara ọbara ọgbụgba - mgbu, itching na ọbara ọgbụgba.

N'ihi nsonaazụ bara uru ya na ngwụcha na nguzogide nke mgbidi isi, Troxevasin ® na-enyere aka belata mmepe nke ọrịa mamịrị retinopathy. Na mgbakwunye, nsonaazụ ya na akụrụngwa nke rheological nke ọbara na-enyere aka gbochie retth vaskụla microthrombosis retinal.

Mlọ ọgwụ

Mgbe nchịkwa ọnụ gasịrị, mmịpụta dị ihe dịka 10-15%. A na-enweta C max na plasma na nkezi awa 2 mgbe a nwesịrị nchịkwa, a na-ejikwa ọkwa ọgwụgwọ na plasma ruo awa asatọ.

Metabolism na ntụpọ

Metabolized na imeju. Akụkụ akụkụ ya ụfọdụ anaghị agbanwe na mmamịrị (20-22%) yana jiri nwa (60-70%).

Usoro usoro onunu ogwu

A na-ewere ọgwụ ọnụ, ya na nri. Ekwesịrị iji mmiri zuru ezu were ihe dị ka mmiri jupụta Capsules.

Na mbido ọgwụgwọ, a na-enye 300 mg (1 okpu.) 3 ugboro / ụbọchị. Mmetụta ahụ na-etolite n'ime izu abụọ, mgbe nke a gasịkwara usoro a na otu usoro ma ọ bụ belata na obere mmezi nke 600 mg, ma ọ bụ kwụsịtụrụ (ebe nsonaazụ a rụpụtara na-adịgide ma ọ dịkarịa ala izu anọ). Usoro ọgwụgwọ a na-enwe ihe dị ka izu 3-4 ruo afọ isii;

Na ọrịa retinopathy nke ọrịa mamịrị, a na-atụ aro maka 0.9-1.8 g / ụbọchị.

Ime na lactation

A na - egbochi ọgwụ iji Troxevasin drug n'oge ọnwa atọ mbụ nke afọ ime.

N'ime oge abụọ nke II na nke III na n’oge a na-enye nwa ara (ịmụ nwa), iji ọgwụ eme ihe ga-ekwe omume mgbe uru a tụrụ anya na usoro ọgwụgwọ maka nne ga-akarị ihe ize ndụ nke nwa ebu n’afọ ma ọ bụ nwa ọhụrụ.

Ntụziaka pụrụ iche

Ọ bụrụ na n’oge ị ofụ ọgwụ ahụ ogo ogo mgbaàmà nke ọrịa anaghị ibelata, ị kwesịrị ịkpọtụrụ dọkịta gị.

Iji Ọrịa Pmụaka

Ahụmahụ eji ojiji nke ọgwụ Troxevasin ® na ụmụaka na-erubeghị afọ 15 ezughị, nke chọrọ ịkpachara anya na ojiji a.

Mmetụta ikike ịkwọ ụgbọ ala na usoro nchịkwa

Theakingụ ọgwụ ahụ anaghị emetụta mmeghachi omume nke moto na nke uche, ọ naghị egbochi ịkwọ ụgbọala yana iji usoro.

AKTAVIS GROUP AO (Iceland)